Department of Vascular Medicine, Amsterdam UMC, University of Amsterdam, Amsterdam Cardiovascular Sciences, Amsterdam, The Netherlands.
Department of Cardiology, Amsterdam UMC, Vrije Universiteit, Amsterdam Cardiovascular Sciences, Amsterdam, The Netherlands.
Heart. 2022 Jan;108(1):61-66. doi: 10.1136/heartjnl-2021-319804. Epub 2021 Sep 30.
To assess whether patients with aortic valve stenosis (AS) with elevated lipoprotein(a) (Lp(a)) are characterised by increased valvular calcification activity compared with those with low Lp(a).
We performed F-sodium fluoride (F-NaF) positron emission tomography/CT in patients with mild to moderate AS (peak aortic jet velocity between 2 and 4 m/s) and high versus low Lp(a) (>50 mg/dL vs <50 mg/dL, respectively). Subjects were matched according to age, gender, peak aortic jet velocity and valve morphology. We used a target to background ratio with the most diseased segment approach to compare F-NaF uptake.
52 individuals (26 matched pairs) were included in the analysis. The mean age was 66.4±5.5 years, 44 (84.6%) were men, and the mean aortic valve velocity was 2.80±0.49 m/s. The median Lp(a) was 79 (64-117) mg/dL and 7 (5-11) mg/dL in the high and low Lp(a) groups, respectively. Systolic blood pressure and low-density-lipoprotein cholesterol (corrected for Lp(a)) were significantly higher in the low Lp(a) group (141±12 mm Hg vs 128±12 mm Hg, 2.5±1.1 mmol/L vs 1.9±0.8 mmol/L). We found no difference in valvular F-NaF uptake between the high and low Lp(a) groups (3.02±1.26 vs 3.05±0.96, p=0.902). Linear regression analysis showed valvular calcium score to be the only significant determinant of valvular F-NaF uptake (β=0.63; 95% CI 0.38 to 0.88 per 1000 Agatston unit increase, p<0.001). Lp(a) was not associated with F-NaF uptake (β=0.17; 95% CI -0.44 to 0.88, p=0.305 for the high Lp(a) group).
Among patients with mild to moderate AS, calcification activity is predominantly determined by established calcium burden. The results do not support our hypothesis that Lp(a) is associated with valvular F-NaF uptake.
评估主动脉瓣狭窄(AS)患者中脂蛋白(a)(Lp(a))升高者与 Lp(a)水平较低者相比,其瓣叶钙化活性是否增加。
我们对轻至中度 AS(峰值主动脉射流速度为 2 至 4m/s)患者进行 F-氟酸钠(F-NaF)正电子发射断层扫描/计算机断层扫描(PET/CT)检查,并将 Lp(a)高与低的患者进行比较(分别为>50mg/dL 和<50mg/dL)。根据年龄、性别、峰值主动脉射流速度和瓣膜形态对受试者进行匹配。我们采用病变最严重节段的靶/背景比值方法比较 F-NaF 摄取。
共纳入 52 名患者(26 对匹配组)进行分析。平均年龄为 66.4±5.5 岁,44 名(84.6%)为男性,平均主动脉瓣流速为 2.80±0.49m/s。Lp(a)中位数分别为 79(64-117)mg/dL 和高、低 Lp(a)组的 7(5-11)mg/dL。低 Lp(a)组的收缩压和低密度脂蛋白胆固醇(校正 Lp(a))明显更高(141±12mmHg 与 128±12mmHg,2.5±1.1mmol/L 与 1.9±0.8mmol/L)。我们发现高、低 Lp(a)组之间的瓣叶 F-NaF 摄取无差异(3.02±1.26 与 3.05±0.96,p=0.902)。线性回归分析表明,瓣叶钙分数是瓣叶 F-NaF 摄取的唯一显著决定因素(β=0.63;每增加 1000 个 Agatston 单位,β=0.38 至 0.88,p<0.001)。Lp(a)与 F-NaF 摄取无关(β=0.17;高 Lp(a)组的 95%置信区间为-0.44 至 0.88,p=0.305)。
在轻至中度 AS 患者中,钙化活性主要由已建立的钙负荷决定。结果不支持我们的假设,即 Lp(a)与瓣叶 F-NaF 摄取有关。